Latest News for: paradigm

Edit

Two paradigms shaping Iran’s response to the Israel-US war - opinion

The Jerusalem Post 22 Mar 2026
Unlike other regimes, Tehran filters decisions through a theological lens, making its behavior unique and consequential both regionally and internally ....
Edit

Two paradigms shaping Iran’s response to the Israel-US war – opinion

Virtual Jerusalem 22 Mar 2026
Unlike other regimes, Tehran filters decisions through a theological lens, making its behavior unique and consequential both regionally and internally.| Read More JPost.com – Opinion | The Jerusalem Post ....
Edit

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA ...

The Daily Record - Dunn 21 Mar 2026
In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the ....
Edit

Paradigm shift needed to fight ageism

The Star 21 Mar 2026
FROM CLARA JEEVAMANI M. THAMBUSAMY Petaling Jaya Read full story ... .
Edit

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

Pharmiweb 21 Mar 2026
With approval in the EU, Opdivo in combination with brentuximab vedotin is now the first immunotherapy combination approved to treat certain pediatric and adult patients with relapsed or refractory cHL ... and the European Union (EU). The U.S ... The U.S ... .
Edit

"A balancing paradigm I often look at is Starcraft": Total War: Medieval 3 won't lean ...

Rock, Paper, Shotgun 20 Mar 2026
spears beat cavalry, cavalry beat swords, swords beat spears ... Cavalry won't necessarily beat swords if the cavalry are all tuckered out and spooked ... Read more .
Edit

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab) (Bristol-Myers Squibb Company)

Public Technologies 20 Mar 2026
) ... With approval in the EU, Opdivo in combination with brentuximab vedotin is now the first immunotherapy combination approved to treat certain pediatric and adult patients with relapsed or refractory cHL ... and the European Union (EU). The U.S ... The U.S.
Edit

Paradigm Launches Surface, an AI-Native Platform That Connects Culture to Business Performance

Ravalli Republic 18 Mar 2026
New talent and culture intelligence platform helps talent leaders unify fragmented people data, benchmark practices against peers, and turn insights into action in minutes instead of months ... .
Edit

Former FSCS CEO joins Paradigm Norton as NED

Financial Planning Today 18 Mar 2026
Paradigm Norton Financial Planning has appointed former FSCS chief executive Caroline Rainbird as a Non-Executive Director (NED) ... Philippa Hann, CEO at Paradigm Norton said.
Edit

Tempo Taps RedStone as Core Oracle Partner in Stripe and Paradigm’s Blockchain Push

Crypto Economy 18 Mar 2026
RedStone was selected as the oracle provider for Tempo, the payments blockchain developed by Stripe and Paradigm, following an exhaustive market evaluation.
Edit

On the Move: Paradigm Norton; Simpkins Edwards; Parker’s

The Business Desk 17 Mar 2026
X Register for free to receive latest news stories direct to your inbox. Register. Paradigm Norton Financial Planning, which has offices in Bristol and Exeter, has appointed Caroline Rainbird as a non-executive director ... She said ... ... .... Turner said ... .
Edit

JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity (Form 6-K) (Neurosense Therapeutics Ltd)

Public Technologies 16 Mar 2026
JAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity ... Key highlights from the PARADIGM phase 2b study published ● Strong safety and tolerability profile.
×